New - European Medical Journal

Continue

News

Oncology
30 Jun 2016

Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer

Barcelona-Lugano, June 30, 2016 – Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients…
General Healthcare
30 Jun 2016

Chemoradiotherapy after Surgery for Gastric Cancer Shows Similar Outcomes to Post-Operative Chemotherapy

Barcelona-Lugano, June 30, 2016 – Post-operative treatment intensification with chemoradiotherapy does not achieve better outcomes when compared to…
Oncology
29 Jun 2016

Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition

June 29, 2016 – Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with…
EMJ
Hepatology
27 Jun 2016

Protein Successfully Predicts Recurrence of Liver Cancer

INVESTIGATIONS of p62 have highlighted the protein as a key factor in cancer recurrence and has been associated with reduced rates of survival in liver…
EMJ
Hepatology
27 Jun 2016

Restricted Calorie Intake Reduces Fat Content of Liver

GROWING rates of obesity have raised concerns regarding the resulting metabolic diseases caused by overeating, such as Type 2 diabetes and liver disease…
Gastroenterology
22 Jun 2016

IBD Drug Availability Putting Children at Risk of Lifelong Health Complications

June 21, 2016 – To halt the health risks for children and improve outcomes in the future, IBD experts across Europe are calling for an urgent increase in…
Cardiology
22 Jun 2016

Richard Wolf Presents Its Profile at the 24th International Congress of the E.A.E.S in Amsterdam

June 16, 2016 – Particularly in contemporary medicine, the importance of efficient processes is steadily increasing on account of the rising pressure…
Cardiology
22 Jun 2016

iVascular Completes Recruitment of Patients for Its ANCHOR Clinical Trial of the Sirolimus Eluting Stent ANGIOLITE

May 19, 2016 – Coordinated by PI Dr. Josep Rodés-Cabau from Quebec Heart and Lung Institute, the objective of ANCHOR clinical trial is to perform a…